Acute respiratory distress syndrome: Update on the latest developments in basic and clinical research

Current Opinion in Anaesthesiology

Volumn 18, Issue 2, 2005, Pages 137-145

  Bosma, Karen ^a   Fanelli, Vito ^a   Ranieri, V Marco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Clinical trials

Indexed keywords

ACETYLCYSTEINE; CORTICOSTEROID; DIPALMITOYLPHOSPHATIDYLCHOLINE; IBUPROFEN; KETOCONAZOLE; LISOFYLLINE; LUNG SURFACTANT; LUSUPULTIDE; METHYLPREDNISOLONE; NITRIC OXIDE; PLACEBO; PROSTAGLANDIN E1; SIVELESTAT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CRITICAL ILLNESS; FLUID BALANCE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LUNG VENTILATION; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT POSITIONING; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEROID THERAPY; SURVIVAL; TIDAL VOLUME;

EID: 17144369537     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000162831.41097.6b     Document Type: Review

References (102)

1. Bernard GR, Artigas A, Brigham KL, et al. The American - European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-824.
2. Esteban A, Fernandez-Segoviano P, Frutos-Vivar F, et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 2004; 141:440-445. This is the first study to determine the sensitivity, specificity and likelihood ratio of the 1994 AECC clinical criteria for ARDS diagnosis, compared with pathologic diagnosis at autopsy.
3. Rubenfeld GD, Caldwell E, Granton J, et al. Intel-observer variability in applying a radiographic definition for ARDS. Chest 1999; 116:1347-1353.
4. Gowda MS, Klocke RA. Variability of indices of hypoxemia in adult respiratory distress syndrome. Crit Care Med 1997; 25:41-45.
5. Villar J, Perez-Mendez L, Kacmarek RM. Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome. Intensive Care Med 1999; 25:930-935.
6. National Institute of Health. Mechanisms of acute respiratory failure. Am Rev Respir Dis 1977; 115:1071-1078.
7. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. ARDS Network. Incidence of acute lung injury in the United States. Crit Care Med 2003; 31:1607-1611.
8. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001; 29(7 Suppl):S109-S116.
9. Rubenfeld GD. Epidemiology of acute lung injury. Crit Care Med 2003; 31(4 Suppl):S276-S284.
10. Brun-Buisson C, Minelli C, Bertolini G, et al. ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units: results from the ALIVE study. Intensive Care Med 2004; 30:51-61. This important epidemiologic study prospectively collected data over a 2-month period in 1999 on 6522 admissions in 78 ICUs in 10 European countries to redefine incidence and outcome of ALI/ARDS in Europe.
11. Bersten AD, Edibam C, Hunt T, Moran J. Australian and New Zealand Intensive Care Society Clinical Trials Group. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med 2002; 165:443-448.
12. Esteban A, Anzueto A, Frutos F, et al. Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287:345-355.
13. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
14. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349.
15. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 1998; 157(4 Pt 1):1159-1164.
16. Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med 1998; 158:1076-1081.
17. Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med 1999; 159:1849-1861.
18. Luhr OR, Karlsson M, Thorsteinsson A, et al. The impact of respiratory variables on mortality in non-ARDS and ARDS patients requiring mechanical ventilation. Intensive Care Med 2000; 26:508-517.
19. Roupie E, Lepage E, Wysocki M, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. SRLF Collaborative Group on Mechanical Ventilation. Societe de Reanimation de Langue Francaise. Intensive Care Med 1999; 25:920-929.
20. Sakr Y, Vincent JL, Le Gall J-R, et al. High tidal volume and positive fluid balance in acute lung injury are associated with worse outcome [abstract]. Chest 2003; 124:1805.
21. Herridge MS, Cheung AM, Tansey CM, et al. Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693. An important paper describing long-term morbidity and respiratory recovery in survivors of ARDS.
22. Hopkins RO, Weaver LK, Collingridge D, et al. Two year cognitive, emotional, and quality of life in acute respiratory distress syndrome. Am J Respir Crit Care Med 2004; 12 November [Epub ahead of print]. This paper provides information on the neurocognitive and psychiatric sequelae of ARDS at a longer time interval (2 years) than previous studies reporting short-term outcome.
23. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz 1993; 1:538-549.
24. Agouridakis P, Kyriakou D, Alexandrakis MG, et al. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 2002; 3:25.
25. Bouros D, Alexandrakis MG, Antoniou KM, et al. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome. BMC Pulm Med 2004; 4:6. A provocative study which demonstrates that BALF and serum levels of some cytokines have excellent negative predictive value for ARDS development and correlate with outcomes for patients with ARDS. See also Ref. [24] for previous work by the same authors.
26. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of Inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073.
27. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995; 108:1303-1314.
28. Chollet-Martin S, Jourdain B, Gibert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 154(3 Pt 1);594-601.
29. Folkesson HG, Matthay MA. Inhibition of CD18 or CD11b attenuates acute lung injury after acid instillation in rabbits. J Appl Physiol 1997; 82:1743-1750.
30. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003; 31(4 Suppl):S195-S199. This review discusses the contribution of neutrophits to the development and progression of ALI and highlights the major intracellular signalling pathways that are involved in neutrophil activation.
31. Laufe MD, Simon RH, Flint A, Keller JB. Adult respiratory distress syndrome in neutropenic patients. Am J Med 1986;80:1022-1026.
32. Steinberg JM, Schiller HJ, Halter JM, et al. Alveolar instability causes early ventilator-induced lung injury independent of neutrophils. Am J Respir Crit Care Med 2004; 169:57-63. In this animal model, in-vivo video microscopy and computer image analysis were used to assess alveolar stability following surfactant deactivation. Only lung areas with unstable alveoli developed significant histopathology, and this was independent of neutrophil-derived proteases.
33. Haitsma JJ, Papadakos PJ, Lachmann B. Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2004; 10:18-22. This paper provides an excellent review of the composition and role of endogenous surfactant, and an up-to-date review of the current trial of exogenous surfactant replacement therapy in ARDS.
34. Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung injury. Crit Care Med 2003; 31 (Suppl):S324-S328. This paper is also an excellent review of surfactant function in the normal lung, surfactant disruption in the injured lung, factors affecting the outcome of previous surfactant trials, and future directions for surfactant therapy.
35. Ito Y, Veldhuizen RA, Yao LJ, et al. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am J Respir Crit Care Med 1997; 155:493-499.
36. Zhu S, Ware LB, Geiser T, et al. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163:166-172.
37. Baron RM, Carvajal IM, Fredenburgh LE, et al. Nitric oxide synthase-2 down-regulates surfactant protein-B expression and enhances endotoxin-induced lung injury in mice. FASEB J 2004; 18:1276-1278. This work examines one mechanism for regulation of gene expression in acute lung injury, which is an important area of basic science research in the pathogenesis of ARDS.
38. Slutsky AS. Mechanical ventilation. American College of Chest Physicians' Consensus Conference. Chest 1993; 104:1833-1859.
39. Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999; 116:9S-15S.
40. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974; 110:556-565.
41. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159-11 64.
42. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149:1327-1334.
43. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotraumas to biotrauma. Proc Ass Am Physicians 1998; 110:482-488.
44. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157(6 Pt 1):1721-1725.
45. Uhlig S. Ventilation-induced lung injury and mechanotransduction: stretching it too far? Am J Physiol Lung Cell Mol Physiol 2002; 282:L892-L896.
46. Haitsma JJ, Uhlig S, Goggel R, et al. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med 2000; 26:1515-1522.
47. Murphy DB, Cregg N, Tremblay L, et al. Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 2000; 162:27-33.
48. Verbrugge SJ, Sorm V, van't Veen A. et al. Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation. Intensive Care Med 1998; 24:172-177.
49. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 282:54-61.
50. Shyy JY, Lin MC, Man J, et al. The cis-acting phorbol ester '12-O-tetradecanoylphorbol 13-acetate'-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci U S A 1995; 92:8069-8073.
51. Parker JC, Ivey CL, Tucker JA. Gadolinium prevents high airway pressure-induced permeability increases in isolated rat lungs. J Appl Physiol 1998; 84:1113-1118.
52. Waters CM, Ridge KM, Sunio G, et al. Mechanical stretching of alveolar epithelial cells increases Na(+)-K(+)-ATPase activity. J Appl Physiol 1999; 87:715-721.
53. Tschumperlin DJ, Oswari J, Margulies AS. Deformation-induced injury of alveolar epithelial cells: effect of frequency, duration, and amplitude. Am J Respir Crit Care Med 2000; 162(2 Pt 1):357-362.
54. Hubmayr RD, Shore SA, Fredberg JJ, et al. Pharmacological activation changes stiffness of cultured human airway smooth muscle cells. Am J Physiol 1996; 271(5 Pt 1):C1660-C1668.
55. Imai Y, Parodo J, Kajikawa O, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289:2104-2112. An important study demonstrating that injurious mechanical ventilation can lead to epithelial cell apoptosis in the kidney and small intestine, thereby providing a link between ventilator-induced lung injury and multi-organ dysfunction.
56. Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999; 116(1 Suppl):9S-15S.
57. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354.
58. Brower RG, Shanholtz CB, Fessier HE, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 17:1492-1498.
59. Brochard L, Roudot-Throraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158:1831-1838.
60. Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 1998; 338:355-361.
61. Tobin MJ. Culmination of an era in research on the acute respiratory distress syndrome [editorial]. N Engl J Med 2000; 342:1360-1361.
62. Brower RG. Mechanical ventilation in acute lung injury and ARDS: tidal volume reduction. Crit Care Clin 2002; 18:1-13.
63. 2, in conjunction with low tidal volumes.
64. The ARDS Clinical Trials Network. Effects of recruitment maneurvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med 2003; 31:2592-2597.
65. Gattinoni L, Tognoni G, Pesenti A, et al. Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001; 345:568-573.
66. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004; 292:2379-2387. Although just recently published, the protocol for this study was designed and implemented before the results of the trial by Gattinoni et al. (see Ref. [65]) were reported. The protocol for prone positioning in this study did not influence mortality, confirming the results of the previously reported trial.
67. Derdak S, Mehta S, Stewart T, et al. High frequency oscillatory ventilation for acute respiratory distress syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2002; 166:801-808.
68. Mehta S, Granton J, MacDonald R, et al. High-frequency oscillatory ventilation in adults: the Toronto experience. Chest 2004; 126:518-527. This retrospective chart review summarizes the experience of using HFOV in a cohort of adults with ARDS and is hypothesis-generating regarding the role of HFOV as a rescue therapy for patients with severe oxygenation.
69. Humphrey H, Hall J, Sznajder I, et al. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97:1176-1180.
70. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992; 145:990-998.
71. Eisenberg PR, Hansbrough JR, Anderson D, Schuster DP. A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis 1987; 136:662-668.
72. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182.
73. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147:218-233.
74. Lachmann B. The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL, editor. Update in intensive care and emergency medicine. Berlin: Springer; 1987. pp. 123-124.
75. Richman PS, Spragg RG, Robertson B, et al. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J Suppl 1989; 3:109s-111s.
76. Nosaka S, Sakai T, Yonekura M, Yoshikawa K. Surfactant for adults with respiratory failure [letter]. Lancet 1990; 336:947-948.
77. Spragg RG, Gilliard N, Richman P, et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105:195-202.
78. Weg JG, Balk RA, Tharratt RS, et al. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994; 272:1433-1438.
79. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315.
80. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996; 334:1417-1421.
81. Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein c-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351:884-892. A large multi-centre RCT assessing the efficacy of a synthetic surfactant in ARDS; although a negative trial, subgroup analysis generated the hypothesis that this surfactant preparation may benefit patients with direct ARDS when used for a longer treatment period.
82. Weigelt JA, Norcross JF, Borman KR, Snyder WH III. Early steroid therapy for respiratory failure. Arch Surg 1985; 120:536-540.
83. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 31 7:1565-1570.
84. Adhikari N, Burns KEA, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. The Cochrane Database of Systematic Reviews 2004; (4):CD004477. This database provides a metaanalysis for effectiveness of prostaglandin E1, N-acetylcysteine, early high-dose corticosteroids, and surfactant for treatment of ARDS, and a systematic review of other studies not incorporated in the metaanalysis.
85. Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch Surg 1985; 120:530-535.
86. Hooper RG, Kearl RA. Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J 1996; 89:359-364.
87. Meduri GU, Belenchia JM, Estes RJ, et al. Fibroproliferative phase of ARDS: clinical findings and effect of corticosteroids. Chest 1991; 100:943-952.
88. Biffl WL, Moore FA, Moore EE, et al. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg 1995; 170:591-596.
89. Braude S, Haslam P, Hughes D, et al. Chronic adult respiratory distress syndrome: a role for corticosteroids? Crit Care Med 1992; 20:1187-1189.
90. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA 1998; 280:159-165,
91. Marras T, Herridge M, Mehta S. Corticosteroid therapy in acute respiratory distress syndrome. Intensive Care Med 1999; 25:1191-1193.
92. Meduri GU, Carratu P, Freire AX. Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS. Eur Respir J 2003; 22(Suppl 42):57s-64s. This paper provides detailed explanations of the role of nuclear factor-κB and glucocorticoid receptors and establishes a biological rationale for prolonged steroid administration in unresolving ARDS.
93. •]) and describes factors affecting the cellular response to glucocorticosteroids.
94. Zeiher BG, Artigas A, Vincent JL. et al. for the STRIVE study group. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32:1695-1702. A large RCT enrolling 492 patients which fails to show survival benefit with sivelestat, an inhibitor of neutrophil elastase.
95. Tamakuma S, Shiba T, Hirasawa H, et al. A phase III clinical study of neutrophil elastase inhibitor ONO-5046 Na in SIRS patients. J Clin Ther Med (Japan) 1998; 14:289-318.
96. Bernard GR, Wheeler AP, Russel JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336:912-918.
97. The ARDS Network. Ketoconazoie for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283:1995-2002 [errata in JAMA 2000; 284:2450, 2597 and 2001; 286:1578].
98. The ARDS Network. Ketoconazoie for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283:1995-2002 [errata in JAMA 2000; 284:2450, 2597 and 2001; 286:1578].
99. The ARDS Network. Ketoconazoie for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283:1995-2002 [errata in JAMA 2000; 284:2450, 2597 and 2001; 286:1578].
100. The Acute Respiratory Distress Syndrome Network. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002; 30:1-6.
101. Taylor RW, Zimmerman JL, Dellinger RP, et al. Inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291:1603-1609.
102. Sokol J, Jacobs SE, Bonn D. Inhaled nitric oxide for hypoxic respiratory failure in children and adults: a meta-analysis. Anesth Analg 2003; 97:989-998.